New Study Examines ME/CFS Subgroups Based on Cerebrospinal Fluid and Blood-Plasma Proteins

Dr. Akiko Iwasaki, Sterling Professor of Immunology at Yale University and winner of the 2025 Solve Catalyst Award, recently published a study on distinguishing groups of people with ME/CFS based […]
Solve Selects Simmaron Research As Recipient of ME/CFS Catalyst Award to Accelerate Low-Dose Rapamycin Trial for ME/CFS, Long COVID, and IACCs

Solve M.E. is proud to announce that we’ve selected the Simmaron Research Institute as the winner of our second Solve ME/CFS Catalyst Award for its study, “Low Dose Rapamycin in […]